sarscov
envelop
positivestrand
rna
viru
coronavirida
famili
figur
coronavirus
associ
varieti
enter
respiratori
diseas
syndrom
sever
anim
speci
two
recogn
human
coronavirus
sarscov
oc
e
definit
associ
upper
respiratori
ill
sarscov
first
cultur
vero
cell
autopsi
tissu
bronchoalveolar
lavag
nasal
swab
sampl
obtain
patient
hospit
hong
kong
canada
germani
singapor
identif
electron
microscopi
complet
genom
sequenc
aetiolog
role
sarscov
confirm
replic
ill
similar
seen
among
human
experiment
infect
cynomolgu
macaqu
follow
reisol
viru
detect
specif
immun
respons
infect
genom
sequenc
sarscov
quit
distinct
human
anim
suggest
viru
like
circul
natur
reservoir
consider
period
time
search
origin
sarscov
potenti
reservoir
ongo
mani
earli
sar
case
guandong
occur
among
peopl
involv
anim
trade
food
peopl
involv
anim
trade
guandong
like
antibodi
sarscov
trade
anim
gener
popul
addit
coronaviru
homolog
human
sarscov
isol
recov
civet
cat
racoon
dog
sold
live
food
market
collect
observ
support
hypothesi
sarscov
first
transmit
wild
anim
use
food
human
subsequ
persontoperson
transmiss
experiment
studi
shown
ferret
domest
cat
also
suscept
infect
sarscov
effici
transmit
viru
previous
uninfect
anim
hous
clue
anim
reservoir
sarscov
might
provid
studi
wild
domest
anim
anim
market
guandong
genom
sequenc
analysi
viral
isol
obtain
speci
well
human
patient
studi
also
demonstr
presenc
antibodi
sarscov
sarscovlik
viru
small
proport
healthi
adult
hong
kong
sera
bank
may
least
year
prior
sar
find
suggest
sar
may
transmit
period
past
anim
human
viru
may
evolv
adapt
human
infect
chanc
event
result
effici
transmiss
led
outbreak
site
initi
infect
sarscov
unknown
pathogenesi
sar
complet
understood
angiotensinconvert
enzym
recent
identifi
function
sarscov
effici
express
lung
heart
kidney
gastrointestin
tissu
human
sarscov
isol
cell
cultur
autopsi
specimen
lung
intestin
kidney
tissu
patient
die
sarscov
rna
also
detect
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
plasma
serum
patient
first
week
patholog
find
lung
sar
patient
first
day
ill
includ
pneumocyt
prolifer
desquam
hyalin
membran
format
mix
inflammatori
infiltr
intraalveolar
increas
number
interstiti
alveolar
macrophag
focal
haemophagocytosi
interstiti
macrophag
also
describ
case
longer
durat
diffus
alveolar
damag
squamou
metaplasia
multinucl
giant
cell
macrophag
origin
observ
biopsi
autopsi
specimen
colon
termin
ileum
sar
patient
show
rel
normal
architectur
evid
villou
atrophi
inflammatori
distinct
histopatholog
chang
describ
tissu
role
cytokin
immunopathogen
mechan
sar
investig
lymphopaenia
common
among
patient
sar
lymphocyt
count
reduc
nearli
sar
patient
reduct
circul
level
lymphocyt
b
lymphocyt
natur
killer
cell
also
lymphocyt
count
fall
earli
cours
ill
low
level
associ
sever
ill
presenc
lymphopaenia
patholog
manifest
diffus
alveolar
damag
destruct
white
pulp
spleen
haemophagocytosi
suggest
proinflammatori
cytokin
releas
stimul
alveolar
macrophag
may
major
role
pathogenesi
death
sar
usual
occur
late
cours
ill
week
onset
attribut
adult
respiratori
distress
syndrom
multiorgan
failur
thromboembol
complic
secondari
infect
septic
shock
coinfect
human
metapneumoviru
report
among
patient
laboratoryconfirm
sar
howev
role
coinfect
amplifi
pathogen
sarscov
unknown
sarscov
diseas
median
incub
period
approxim
day
patient
becom
ill
within
day
exposur
common
initi
symptom
fever
often
accompani
headach
myalgia
malais
chill
rigor
respiratori
symptom
typic
begin
day
onset
fever
may
present
onset
onethird
patient
lower
respiratori
tract
symptom
common
typic
includ
nonproduct
cough
later
onset
dyspnoea
upper
respiratori
symptom
rhinorrhoea
sore
throat
seen
less
patient
diarrhoea
report
present
approxim
patient
although
symptom
observ
mani
patient
affect
outbreak
apart
complex
hong
kong
believ
result
fecaloralrespiratori
transmiss
respiratori
sign
rale
rhonchi
present
less
onethird
case
sever
often
correl
find
seen
chest
radiograph
elderli
patient
underli
chronic
ill
renal
failur
sometim
present
atyp
symptom
includ
absenc
gener
sar
appear
milder
haematolog
abnorm
includ
lymphopaenia
patient
thrombocytopaenia
prolong
activ
partial
thromboplastin
time
elev
level
lactat
dehydrogenas
alanin
aspart
aminotransferas
creatinin
phosphokinas
none
laboratori
find
reliabl
discrimin
sarscov
diseas
atyp
pneumonia
chest
radiograph
may
normal
patient
evalu
earli
ill
highresolut
chest
comput
tomographi
scan
detect
abnorm
twothird
patient
normal
chest
nearli
everyon
sarscov
diseas
develop
radiograph
evid
pneumonia
ill
day
radiograph
abnorm
typic
begin
isol
focal
ground
glass
opac
predomin
peripher
locat
often
lower
lobe
progress
sever
day
focal
multifoc
diffus
consolid
involv
addit
lobe
lung
mediastin
lymphadenopathi
cavit
atelectasi
pleural
effus
uncommon
patient
sarscov
diseas
requir
mechan
ventil
half
peopl
die
despit
ventil
therapi
sever
ill
risk
death
sar
increas
advanc
age
presenc
certain
underli
medic
condit
particularli
diabet
overal
casefat
rate
approxim
increas
peopl
older
age
global
epidem
case
probabl
sar
death
report
countri
greatest
number
report
case
includ
mainland
china
n
hong
kong
special
administr
region
n
taiwan
n
singapor
n
canada
n
health
care
facil
sever
affect
transmiss
hospit
major
factor
amplif
outbreak
addit
health
care
worker
account
case
global
patient
ward
sar
patient
visitor
hospit
affect
exampl
case
report
april
june
toronto
canada
occur
among
health
care
worker
result
exposur
hospit
occur
among
hospit
health
care
facil
household
sar
patient
second
common
set
sarscov
transmiss
survey
hong
kong
singapor
indic
peopl
household
sar
patient
may
secondarili
risk
transmiss
greatest
among
involv
direct
patient
care
close
contact
patient
transmiss
casual
social
contact
appear
uncommon
secondari
case
document
exposur
workplac
airplan
epidemiolog
sar
outbreak
suggest
sarscov
transmit
primarili
droplet
close
person
contact
conclus
support
find
surgic
mask
confer
protect
studi
document
stabil
viru
day
environ
rais
possibl
fomit
transmiss
instanc
possibl
transmiss
smallparticl
aerosol
exclud
particular
aerosolgener
medic
procedur
eg
endotrach
intub
bronchoscopi
may
associ
increas
risk
transmiss
health
care
given
profus
wateri
diarrhoea
seen
signific
proport
patient
sarscov
shed
larg
quantiti
stool
faec
remain
possibl
sourc
viru
fecalor
fecalrespiratori
spread
lead
hypothes
larg
outbreak
affect
peopl
apart
complex
hong
mathemat
model
studi
indic
sar
case
infect
averag
two
four
howev
sar
patient
effici
transmit
sarscov
suscept
peopl
certain
circumst
lead
socal
superspread
event
superspread
event
occur
number
set
includ
hotel
hong
kong
sar
outbreak
dissemin
global
hospit
mani
locat
factor
contribut
superspread
event
complet
understood
may
relat
inher
greater
infecti
patient
altern
mode
transmiss
exposur
larg
number
contact
environ
conduc
transmiss
asymptomat
sarscov
infect
appear
uncommon
epidemiolog
signific
diseas
transmiss
establish
risk
transmiss
patient
appear
greatest
second
week
correl
time
peak
viral
load
respiratori
time
peak
infecti
might
also
explain
part
predilect
sarscov
spread
health
care
set
patient
seek
medic
care
end
first
week
ill
although
sarscov
rna
detect
fecal
specimen
rtpcr
month
onset
ill
transmiss
document
day
resolut
fever
genom
sequenc
analys
indic
sarscov
isol
outbreak
hong
kong
vietnam
singapor
toronto
taiwan
close
relat
match
viral
isol
obtain
ill
physician
guandong
provinc
support
epidemiolog
conclus
outbreak
directli
indirectli
link
ill
hand
sarscov
isol
guangdong
provinc
exhibit
greater
divers
virus
belong
genet
lineag
differ
global
outbreak
strain
introduc
hong
kong
prior
march
introduct
lead
larg
outbreak
data
rais
question
whether
viral
strain
may
inher
greater
epidem
potenti
hypothesi
need
evalu
altern
differ
transmiss
unrel
viru
strain
ie
superspread
event
could
explain
presenc
absenc
outbreak
associ
independ
human
infect
clinic
manifest
sarscov
diseas
suffici
distinct
respiratori
pathogen
permit
reliabl
differenti
diagnosi
howev
combin
clinic
epidemiolog
featur
provid
clue
diagnosi
document
persontoperson
transmiss
sarscov
worldwid
predilect
sarscov
caus
unusu
cluster
pneumonia
health
care
set
provid
mean
focu
surveil
effort
reemerg
sarscov
confirm
histori
exposur
known
sar
casepati
sarsaffect
area
may
help
earli
recognit
patient
laboratori
diagnosi
sarscov
base
either
detect
viral
rna
clinic
specimen
find
antibodi
direct
sarscov
serum
viral
isol
recommend
routin
diagnosi
low
sensit
biosafeti
hazard
pose
avail
realtim
rtpcr
assay
sarscov
highli
specif
detect
copi
viral
rna
clinic
specimen
low
viral
load
respiratori
fecal
specimen
first
week
ill
limit
clinic
sensit
util
assay
limit
data
suggest
sarscov
rna
detect
serum
sar
patient
first
week
potenti
contamin
posit
rtpcr
result
confirm
test
second
specimen
refer
identif
serolog
antibodi
sarscov
remain
refer
standard
confirm
sarscov
infect
howev
antibodi
usual
detect
first
week
ill
patient
may
mount
antibodi
respons
day
ill
onset
import
note
neither
neg
rtpcr
test
neg
test
serum
obtain
day
ill
onset
reliabl
exclud
infect
sarscov
bodi
fluid
submit
test
patient
suspect
sar
includ
respiratori
tract
secret
serum
whole
blood
stool
lower
respiratori
tract
specimen
eg
sputum
bronchial
alveolar
lavag
fluid
appear
higher
yield
upper
respiratori
tract
specimen
eg
nasal
pharyng
aspir
swab
collect
multipl
specimen
differ
type
like
increas
overal
diagnost
yield
differ
specimen
greater
diagnost
yield
differ
time
ill
tabl
sarscov
test
result
alway
consid
context
clinic
epidemiolog
find
set
sar
humantohuman
transmiss
worldwid
posit
predict
valu
sarscov
test
extrem
low
thu
posit
laboratori
result
must
interpret
extrem
caution
implic
global
public
health
diagnost
assay
respiratori
pathogen
may
help
differenti
sarscov
diseas
ill
sar
patient
may
simultan
infect
sarscov
anoth
respiratori
pathogen
factor
consid
evalu
patient
dual
infect
includ
strength
epidemiolog
exposur
criteria
sarscov
diseas
specif
altern
diagnost
test
compat
clinic
present
cours
ill
altern
diagnosi
absenc
vaccin
effect
drug
natur
immun
sarscov
key
control
sar
classic
public
health
control
strategi
case
identif
contain
measur
prove
effect
associ
cessat
transmiss
throughout
world
juli
key
contain
effort
surveil
system
provid
readi
access
time
inform
number
new
case
like
sourc
exposur
case
number
case
previous
identifi
contact
number
contact
highrisk
exposur
known
case
potenti
prospect
case
sinc
sar
anywher
implic
local
nation
global
essenti
health
care
public
health
commun
exchang
inform
individu
sar
case
statu
sar
transmiss
commun
global
potenti
case
sar
detect
appropri
infect
control
measur
must
implement
immedi
prevent
transmiss
sar
patient
often
requir
hospit
sever
ill
less
sever
ill
sometim
hospit
ensur
strict
isol
procedur
follow
set
patient
manag
residenti
set
evalu
suitabl
purpos
possibl
airborn
transmiss
exclud
patient
requir
hospit
prefer
admit
airborn
infect
isol
room
special
adapt
sar
unit
ward
treat
safe
appropri
set
lack
isol
room
andor
need
concentr
infect
control
effort
resourc
may
lead
strategi
group
patient
individu
room
floor
prove
effect
mani
set
outbreak
health
care
worker
strictli
adher
use
appropri
person
protect
equip
potenti
transmiss
nonsar
patient
hospit
visitor
minim
administr
control
contact
trace
identif
peopl
potenti
expos
case
sar
essenti
prevent
spread
provid
mean
focu
control
effort
peopl
high
risk
sar
identifi
peopl
earli
cours
ill
implement
control
measur
spread
viru
other
contact
trace
evalu
ill
monitor
immedi
high
prioriti
maxim
chanc
rapidli
control
outbreak
outbreak
quarantin
expos
peopl
one
contact
manag
strategi
use
prevent
inadvert
sarscov
exposur
separ
expos
unexpos
potenti
decreas
interv
onset
symptom
institut
control
measur
key
compon
effect
sar
control
strategi
includ
follow
system
rapid
frequent
commun
crucial
inform
sar
educ
train
public
health
health
care
worker
clinic
epidemiolog
aspect
sar
appropri
use
interpret
laboratori
test
best
practic
effect
use
infect
control
strategi
effici
inform
technolog
system
provid
mean
link
clinic
epidemiolog
laboratori
data
sar
case
dissemin
inform
local
nation
global
system
allow
rapid
identif
track
evalu
monitor
contact
sar
case
emerg
sarscov
dramat
illustr
potenti
new
diseas
suddenli
appear
spread
lead
widespread
health
social
econom
consequ
fortun
experi
also
demonstr
power
tradit
public
health
surveil
infect
control
isol
contain
control
sar
outbreak
possibl
predict
sarscov
reappear
whether
caus
similar
outbreak
futur
possibl
sourc
viru
reemerg
sarscov
includ
origin
anim
reservoir
persist
infect
human
laboratori
recent
detect
sarscov
case
china
hypothes
repres
animaltohuman
laboratoryacquir
case
singapor
taiwan
highlight
need
stringent
biosafeti
achiev
type
swift
decis
respons
requir
control
sar
outbreak
must
prepar
learn
mani
lesson
sar
outbreak
prepar
respons
outbreak
sar
requir
coordin
cooper
among
public
health
health
care
emerg
respons
entiti
level
govern
invest
sar
prepared
like
yield
addit
dividend
prepared
battl
emerg
infecti
diseas
threat
public
health
